rethinkPeptides Search
Menu
Home / Research library
Research citation

Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes.

RPEP-048432020Hartman, Mark L; Sanyal, Arun J; Loomba, Rohit; Wilson, Jonathan M; Nikooienejad, Amir; Bray, Ross; Karanikas, Chrisanthi A; Duffin, Kevin L; Robins, Deborah A; Haupt, Axel
evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes.

Diabetes care, 43(6), 1352-1355

View on PubMed ↗Publisher’s paper ↗

Citation

Hartman, Mark L; Sanyal, Arun J; Loomba, Rohit; Wilson, Jonathan M; Nikooienejad, Amir; Bray, Ross; Karanikas, Chrisanthi A; Duffin, Kevin L; Robins, Deborah A; Haupt, Axel. (2020). Effects of Novel Dual GIP and GLP-1 Receptor Agonist Tirzepatide on Biomarkers of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes.. Diabetes care, 43(6), 1352-1355. https://doi.org/10.2337/dc19-1892